|Mr. David A. Rosa M.D.||President, CEO & Director||661.41k||N/A||1964|
|Mr. Ronald W. McClurg||Chief Financial Officer||344.06k||N/A||1959|
|Mr. Steven Mertens||Chief Technology Officer||305.97k||N/A||1963|
|Mr. Mark Christianson||Co-Founder, Business Development Director & Medical Sales Liaison||260.85k||N/A||1967|
|Mr. Christopher R. Volker CFA||Chief Operating Officer||N/A||N/A||N/A|
|Mr. Hijaz Haris||Vice President of Marketing||N/A||N/A||N/A|
NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.
NeuroOne Medical Technologies Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.